The approach to cancer care during the pandemic has required balancing the risk of exposure to, and harm from, SARS-Cov-2 infection against the benefits of treatment and the optimal use of health system resources while maximising patient outcomes.
Some new or modified healthcare practices will be of long-term value in improving quality and resilience in cancer care.
COVID-19 Recovery: Implications for cancer care describes:
- elements of cancer care which have changed during the COVID-19 pandemic
- the impacts of these changes
- targeted strategies (at the system-level, service-level, practitioner-level, and patient-level) to retain, enhance, and embed high-value changes into practice.
This report is informed by:
- National and international literature
- Input and consensus from leading Australian cancer experts and consumer representatives.
Strategies to embed and enhance high-value care
COVID-19 Recovery: Implications for cancer care includes a number of targeted strategies to prompt considerations and future approaches to support high-value cancer care in the Recovery phases of the COVID-19 pandemic.
- System-level strategies involve activities at the health system level (national or jurisdictional) to identify and address system-wide cancer control needs, support high-value cancer care and improve outcomes for people with cancer
- Service-level strategies involve activities at the health service level (including specialist and primary care, in both the public and private sectors) to support high-value cancer care and improve outcomes for people with cancer
- Practitioner-level strategies involve activities by a range of cancer control stakeholders across the Australian health system to support health professionals to deliver high-value cancer care and improve outcomes for people with cancer
- Patient-level strategies involve activities directly affecting patients and consumer advocacy organisations to support high-value cancer care and improve outcomes for people with cancer.
Last updated 14 February 2025